Skyline Medical, Electronic On-Ramp and GLG Pharma Senior Management to be Interviewed on WPSL AM 1590
September 26 2016 - 7:30AM
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or
“the Company”), producer of the FDA-approved STREAMWAY® System for
automated, direct-to-drain medical fluid disposal, announced today
that Dr. Carl Schwartz, Interim Chief Executive Officer of Skyline
Medical; Bob Beringer, Chief Executive Officer of Electronic
On-Ramp; and Richard Gabriel, Co-founder and Chief Operating
Officer of GLG Pharma, LLC. will be interviewed on WPSL’s
“MONEYINFO by PRINCETON RESEARCH with MIKE KING and
CHARLES MOSKOWITZ” show on Tuesday, September 27th. The show
will begin at 10:05 a.m. Eastern time and management’s interview
will begin at 10:20 a.m.
Management is expected to discuss recent news
that Skyline Medical has signed a partnership agreement with GLG,
which intends to develop rapid diagnostic tests that utilize fluid
and tissue collected by the STREAMWAY System during procedures, and
its expected joint venture with Electronic On-Ramp to supply
STREAMWAY to U.S. government mobile operating rooms, including
disaster relief sites.
To listen to the interview live, investors may
visit WPSL’s website at www.wpsl.com. A replay will be
available on the investor relations section of Skyline Medical’s
website at www.skylinemedical.com.
About Skyline Medical
Inc.Skyline Medical Inc. produces a fully automated,
patented, FDA-cleared, waste fluid disposal system that virtually
eliminates staff exposure to blood, irrigation fluid and other
potentially infectious fluids found in the healthcare environment.
Antiquated manual fluid handling methods — which require hand
carrying and emptying filled fluid canisters — present an exposure
risk and potential liability. Skyline Medical's STREAMWAY System
fully automates the collection, measurement and disposal of waste
fluids and is designed to: 1) reduce overhead costs to hospitals
and surgical centers, 2) improve compliance with OSHA and other
regulatory agency safety guidelines, 3) improve efficiency in the
operating room, and radiology and endoscopy departments — leading
to greater profitability, and 4) provide greater environmental
stewardship by helping to eliminate the approximately 50 million
potentially disease-infected canisters that go into landfills
annually in the United States. For additional information, please
visit www.skylinemedical.com.
Contact:
Investors
LHA
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
or
Bruce Voss
bvoss@lhai.com
310-691-7100
Precision Therapeutics Inc. (NASDAQ:AIPT)
Historical Stock Chart
From Apr 2024 to May 2024
Precision Therapeutics Inc. (NASDAQ:AIPT)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Precision Therapeutics Inc. (NASDAQ): 0 recent articles
More News Articles